Skip to main content
Log in

Animal Pharmacology of Nebivolol

  • Section 1
  • Published:
Drug Investigation Aims and scope Submit manuscript

Summary

Nebivolol is a mixture of equal amounts of 2 enantiomers: SR3-nebivolol (d-nebivolol) and RS3-nebivolol (l-nebivolol). SR3-nebivolol is a potent and selective β1-adrenergic antagonist both in vitro and in vivo. Nebivolol acutely lowers blood pressure in spontaneously hypertensive rats and induces a slight decrease in total peripheral vascular resistance and a slight increase in cardiac output in anaesthetised dogs. These haemodynamic effects cannot be explained by β1-adrenergic antagonism and are largely attributable to RS3-nebivolol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Azuma H, Ishikawa M, Sekizaki S. Endothelium-dependent inhibition of platelet aggregation. British Journal of Pharmacology 88: 411–415, 1986

    Article  PubMed  CAS  Google Scholar 

  • Blankestijn PJ, Tulen J, Boomsma F, van Eck HJR, Mulder P, et al. Support for adrenaline-hypertension hypothesis: 18 hour pressor effects after 6 hours adrenaline infusion. Lancet 2: 1386–1388, 1988

    Article  PubMed  CAS  Google Scholar 

  • Clarke DE, Bond RA, Charlton KG, Blue DR. Pre-synaptic 5-HT receptors mediating inhibition of transmitter release from peripheral cholinergic and noradrenergic nerves. In Mylecharane EJ et al. (Eds) Serotonin. Actions, receptors, pathophysiology, pp. 48–55, MacMillan Press Ltd, London, 1989

    Google Scholar 

  • De Clerck F, Van Gorp L, Loots W, Janssen PAJ. Differential effects of nebivolol, atenolol and propranolol on heart rate and on bronchoconstrictor responses to histamine in the guinea-pig. Archives Internationales de Pharmacologie et de Thérapie 298: 230–236, 1989

    Google Scholar 

  • Fozard JR, Kilbinger H. 8-OH-DPAT inhibits transmitter release from guinea-pig enteric cholinergic neurons by activating 5-HT1A receptors. British Journal of Pharmacology 86: 601P, 1985

    Article  Google Scholar 

  • Fozard JR, Mir AK, Middlemiss DN. Cardiovascular response to 8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. Journal of Cardiovascular Pharmacology 9: 328–347, 1987

    Article  PubMed  CAS  Google Scholar 

  • Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB Journal 3: 2007–2018, 1989

    PubMed  CAS  Google Scholar 

  • Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373–376, 1980

    Article  PubMed  CAS  Google Scholar 

  • Heimburger M, Montero MJ, Fougeres V, Beslot F, Davy M, et al. Presynaptic β-adrenoceptors in rat atria: evidence for the presence of stereoselective β1-adrenoceptors. British Journal of Pharmacology 98: 211–217, 1989

    Article  PubMed  CAS  Google Scholar 

  • Janssens WJ, Van de Water A, Xhonneux R, Reneman RS, Van Nueten JM, et al. Nebivolol is devoid of intrinsic sympathomimetic activity. European Journal of Pharmacology 159: 89–95, 1989

    Article  PubMed  CAS  Google Scholar 

  • Kubo T, Kuwahara M, Misu Y. Effect of isoproterenol on vascular adrenergic neurotransmission in prehypertensive and hypertensive spontaneously hypertensive rats. Japanese Journal of Pharmacology 36: 419–421, 1984

    Article  PubMed  CAS  Google Scholar 

  • Loots W, De Clerck F. Differential effects of nebivolol, propranolol and phentolamine on adrenoceptors in the heart and in skeletal resistance arterioles in the rat. A quantitative intravital microscopical analysis. European Journal of Pharmacology 179: 177–186, 1990

    Article  PubMed  CAS  Google Scholar 

  • Lu HR, Vandeplassche G, Wouters L, Borgers M. β-Blockade in the ischemic reperfused working rabbit heart: dissociation of β-adrenergic blocking and protective effects. Archives Internationales de Pharmacodynamie et de Thérapie 301: 165–181, 1989

    PubMed  CAS  Google Scholar 

  • Majewski H, Alade PI, Rand MJ. Adrenaline and stress-induced increases in blood pressure in rats. Clinical and Experimental Pharmacology and Physiology 13: 283–288, 1986

    Article  PubMed  CAS  Google Scholar 

  • Majewski H, Rand MJ. Prejunctional β-adrenoceptors and hypertension: a hypothesis revisited. Trends in Pharmacological Sciences: 500–502, 1984

  • Majewski H, Rand MJ, Tung L-H. Activation of prejunctional β-adrenoceptors in rat atria by adrenaline applied exogenously or released as a co-transmitter. British Journal of Pharmacology 73: 669–679, 1981a

    Article  PubMed  CAS  Google Scholar 

  • Majewski H, Tung L-H, Rand MJ. Hypertension through adrenaline activation of prejunctional β-adrenoceptors. Clinical and Experimental Pharmacology and Physiology 8: 463–468, 1981b

    Article  PubMed  CAS  Google Scholar 

  • Majewski H, Tung L-H, Rand MJ. Adrenaline-induced hypertension in rats. Journal of Cardiovascular Pharmacology 3: 179–185, 1981c

    Article  PubMed  CAS  Google Scholar 

  • Majewski H, Tung L-H, Rand MJ. Adrenaline activation of prejunctional β-adrenoceptors and hypertension. Journal of Cardiovascular Pharmacology 4: 99–106, 1982

    Article  PubMed  CAS  Google Scholar 

  • Manin’t Veld AJ, Schalekamp MADH. How β-blockers lower blood pressure: divulgence of the non-essentiality of the cardiodepression and renin suppression by partial agonism and the key role of vascular resistance changes. Vascular Medicine 1: 195–218, 1983

    Google Scholar 

  • Manin’t Veld AJ, van den Meiracker A, Schalekamp MADH. The effect of β-blockers on total peripheral resistance. Journal of Cardiovascular Pharmacology 8: S49–S60, 1986

    Article  Google Scholar 

  • Misu Y, Kaiho M, Yasuda G, Kuwahara M, Kubo T. Pharmacological properties of presynaptic β-adrenoceptors in guinea-pig pulmonary arteries. Japanese Journal of Pharmacology 36: 329–337, 1984

    Article  PubMed  CAS  Google Scholar 

  • Misu Y, Kuwahara M, Amano H, Kubo T. Evidence for tonic activation of prejunctional β-adrenoceptors in guinea-pig pulmonary arteries by adrenaline derived from the adrenal medulla. British Journal of Pharmacology 98: 45–50, 1989

    Article  PubMed  CAS  Google Scholar 

  • Misu Y, Kuwahara M, Kubo T. Some relevance of presynaptic β-adrenoceptors to development of hypertension in spontaneously hypertensive rats. Archives Internationales de Pharmacodynamie 287: 299–308, 1987

    CAS  Google Scholar 

  • Pauwels PJ, Gommeren W, Van Lommen G, Janssen PAJ, Leysen JE. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various β-adrenergic blockers. Molecular Pharmacology 34: 843–851, 1988

    PubMed  CAS  Google Scholar 

  • Pauwels PJ, Leysen JE, Janssen PAJ. β-Adrenoceptor-mediated cAMP accumulation in cardiac cells: effects of nebivolol. European Journal of Pharamcology 172: 471–479, 1989

    Article  CAS  Google Scholar 

  • Radomski MW, Palmer RMJ, Moncada S. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. British Journal of Pharmacology 92: 181–187, 1987

    Article  PubMed  CAS  Google Scholar 

  • Richardson BP, Hoyer D. Selective agonists and antagonists at 5-hydroxytryptamine receptor subtypes. In Paoletti R et al. (Eds) Serotonin. From cell biology to pharmacology and therapeutics, pp. 265–276, Kluwer Academic Publishers, Dordrecht, 1990

    Google Scholar 

  • Schlicker E, Erkens K, Göthert M. Probable involvement of vascular angiotensin II formation in the β2-adrenoceptor-mediated facilitation of the neurogenic vasopressor response in the pithed rat. Naunyn-Schmiedeberg’s Archives of Pharmacology 338: 536–542, 1988

    PubMed  CAS  Google Scholar 

  • Schneider J, Fruh C, Wilffert B, Peters T. Effects of the selective β1-adrenoceptor antagonist, nebivolol, on cardiovascular parameters in the pithed normotensive rate. Pharmacology 40: 33–41, 1990

    Article  PubMed  CAS  Google Scholar 

  • Van de Water A, Janssens W, Van Nueten J, Xhonneux R, De Crée J, et al. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective β1-adrenergic antagonist. Journal of Cardiovascular Pharmacology 11: 552–563, 1988a

    Article  PubMed  Google Scholar 

  • Van de Water A, Xhonneux R, Reneman RS, Janssen PAJ. Cardiovascular effects of dl-nebivolol and its enantiomers — a comparison with those of atenolol. European Journal of Pharmacology 156: 95–103, 1988b

    Article  PubMed  Google Scholar 

  • Vincent HH, Boomsma F, Manin’t Veld AJ, Schalekamp ADH. Stress levels of adrenaline amplify the blood pressure response to sympathetic stimulation. Journal of Hypertension 4: 255–260, 1986

    Article  PubMed  Google Scholar 

  • Xhonneux R, Wouters L, Reneman RS, Janssen PAJ. The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer. European Journal of Pharmacology 181: 261–265, 1990

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janssens, W.J., Xhonneux, R. & Janssen, P.A.J. Animal Pharmacology of Nebivolol. Drug Invest 3 (Suppl 1), 13–24 (1991). https://doi.org/10.1007/BF03258258

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03258258

Keywords

Navigation